BYAH

Park Ha Biological Technology Co., Ltd. is a biotechnology company based in China that focuses on developing and commercializing innovative biological products for healthcare applications. The company specializes in research, development, and production of biological drugs and therapeutic solutions targeting various medical conditions. Park Ha leverages advanced biotechnology platforms and manufacturing capabilities to create products that address unmet medical needs in the Chinese healthcare market. The company operates research facilities and production plants equipped with modern biotechnology equipment and quality control systems designed to meet regulatory standards for pharmaceutical manufacturing. Park Ha's business strategy emphasizes innovation in biologics, strategic partnerships with research institutions and healthcare providers, and expansion of its product pipeline to capture opportunities in China's growing biopharmaceutical sector. The company aims to improve patient outcomes through the development of safe and effective biological therapies while building a sustainable business model in the competitive biotechnology industry.